NRx Pharmaceuticals (NRXP) Earnings Date, Estimates & Call Transcripts $1.32 -0.06 (-4.35%) (As of 11/4/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NRx Pharmaceuticals Latest Earnings SummaryUpcoming Q3 Earnings DateNov. 11EstimatedActual EPS (Aug. 14) -$0.75 Beat By $0.06 Consensus EPS (Aug. 14) -$0.81 NRx Pharmaceuticals posted Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.75, which beat analysts' consensus estimates of -$0.81 by $0.06. With a trailing EPS of -$2.69, NRx Pharmaceuticals' earnings are expected to grow next year, from ($3.25) to ($0.95) per share. Conference Call TranscriptConference Call AudioNRXP Upcoming EarningsNRx Pharmaceuticals' next earnings date is estimated for Monday, November 11, 2024, based off prior year's reporting schedules. Get NRx Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NRx Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNRXP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NRXP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyBanking failure dead aheadIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. NRx Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ2 20241-$0.81-$0.81-$0.81 Q3 20241-$0.81-$0.81-$0.81 Q4 20241-$0.86-$0.86-$0.86 NRx Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/11/2024(Estimated)------- 8/14/2024Q2 2024-$0.81-$0.75+$0.06-$0.75-- 5/14/2024Q1 2024--$0.74 -$0.74-$0.74--3/29/2024Q4 2023--$0.50 -$0.50-$0.50--11/13/2023Q3 2023-$11.00-$7.00+$4.00-$0.07--8/14/2023Q2 2023-$14.00-$12.00+$2.00-$0.12--5/16/2023Q1 2023-$15.00-$13.00+$2.00-$0.10-- Get the Latest News and Ratings for NRXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/30/2023Q4 2022-$14.00-$15.00 -$1.00-$0.14--11/14/2022Q3 2022-$14.00-$14.00--$0.14-- NRx Pharmaceuticals Earnings - Frequently Asked Questions When is NRx Pharmaceuticals's earnings date? NRx Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates. Learn more on NRXP's earnings history. Did NRx Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, NRx Pharmaceuticals (NASDAQ:NRXP) reported ($0.75) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.81) by $0.06. Learn more on analysts' earnings estimate vs. NRXP's actual earnings. How can I listen to NRx Pharmaceuticals's earnings conference call? The conference call for NRx Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read NRx Pharmaceuticals's conference call transcript? The conference call transcript for NRx Pharmaceuticals's latest earnings report can be read online. Read Transcript How much profit does NRx Pharmaceuticals generate each year? NRx Pharmaceuticals (NASDAQ:NRXP) has a recorded net income of -$30.15 million. NRXP has generated -$2.69 earnings per share over the last four quarters. What is NRx Pharmaceuticals's EPS forecast for next year? NRx Pharmaceuticals's earnings are expected to grow from ($3.25) per share to ($0.95) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies MNTS Earnings HOFV Earnings EVOK Earnings OSTX Earnings SCYX Earnings OCX Earnings AFMD Earnings QNCX Earnings VOR Earnings ANEB Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Banking failure dead ahead (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. This page (NASDAQ:NRXP) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
